Turku PET Centre
Turku, FI-20521, Finland
NCT Number: NCT01889004
The explanation of consciousness poses one of the greatest challenges to science and philosophy in the 21st century. It remains unclear what consciousness is and how it emerges from brain activity. By studying anesthesia and sleep, the investigators aim to reveal what happens in the brain when consciousness is lost and when it returns. During the study, a series of Positron Emission Tomography (PET), Magnetic Resonance Imaging (MRI) and electroencephalography (EEG) studies will be carried out on healthy male subjects to reveal the neural correlates of consciousness. Consciousness of the subjects will be manipulated with normal sleep and anesthetic agents dexmedetomidine and propofol.
First, various neurophysiological tools to separate consciousness, connectedness and responsiveness during normal sleep will be tested. The most suitable methods and subjects will be selected and then tested during anesthetic-induced sedation and loss of responsiveness (LOR). The anesthetics (dexmedetomidine or propofol) will be administered as target-controlled infusions (TCI) with step-wise concentration-increments until LOR is detected. Then, TCIs are repeated in the same subjects but adjusted according to the individual drug target concentrations sufficient for LOR, and a series of PET perfusion imaging measurements will be performed to obtain the brain activity information in various states of consciousness. The same subjects will then be imaged with PET for brain activity after sleep deprivation (awake), during various sleep stages and immediately after awakening. Finally, ten dexmedetomidine subjects will be given the drug once more, and functional MRI (fMRI) data will be collected at various states of consciousness before and during verbal and nonverbal vocalizations. EEG will be continuously collected in all sessions. The depth of anesthesia will be measured using quantitative EEG and bispectral index (BIS) monitoring.
The results may lead to the discovery of new and better objective indicators of the depth of anesthesia and consciousness, and new insights into the understanding of neural mechanisms behind drug-induced loss of consciousness and ultimately the mechanisms of action of (general) anesthetics as well as consciousness itself.
Looking for future studies?
Notify Me20 year–30 year
Male
Interventional
Phase 4
Turku, FI-20521, Finland
(not needed)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Escalating concentrations until loss of responsiveness
Other names: Dexdor
Escalating concentrations until loss of responsiveness
Other names: Propofol-Lipuro
Time frame: Several measurements during two separate days within 2 months
Altogether 14 PET scans during two separate study days. Cerebral blood flow changes will be used as surrogates for changes in regional brain activity.
Time frame: Continuous data collection during five separate days within 2 months
Time frame: Several measurements during one day
Time frame: Several time points during five separate days within 2 months
Time frame: Several times points during two or three separate days within 2 months
University of Turku
Other
The Neural Mechanisms of Anesthesia and Human Consciousness (LOC-2013)
Acronym: LOC-2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04366544
Behavior, Behavior, Animal
Indianapolis, Indiana, United States
View Trial DetailsNCT06029205
Behavior, Behavioral Symptoms
Çanakkale, Turkey (Türkiye)
View Trial DetailsNCT04653597
Chemically-Induced Disorders, Coma
Paris, France
View Trial DetailsNCT03328221
Acquired Brain Injury, Behavior
Copenhagen, Denmark
View Trial Details